Published in Biotech Business Week, January 1st, 2007
Enhanze Technology is Halozyme's proprietary drug-delivery technology based on its recombinant human hyaluronidase (rHuPH20). rHuPH20 is an analog of a human enzyme that temporarily clears space in the matrix of tissues such as skin. This clearing activity should allow rHuPH20 to improve drug delivery by enhancing the entry of therapeutic molecules through the subcutaneous space.
"Roche is a global leader in the development of biologics and we are excited to be...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.